Nail changes after chemotherapy

Same author

[Beta-thalassemia, 1998].

Medicina clinica·1998

Same author

[Randomized multi-center trial of the administration of erythropoietin in anemia of prematurity].

Anales espanoles de pediatria·1997

Same author

[Serum ferritin for screening in fertile-age women].

Medicina clinica·1997

Same author

[Organizational models for the hematology areas of the district hospitals of Catalonia].

Sangre·1996

Same author

[Intense neutropenia of 14 years duration as the only manifestation of a myelodysplastic syndrome].

Medicina clinica·1995

Same author

[Primary extralymphatic non-Hodgkin's lymphomas: the response to treatment and prognostic factors in 73 patients].

Medicina clinica·1995

Same journal

Emapalumab and eltrombopag rescue for prolonged immune effector cell-associated hemophagocytic syndrome after CAR T-cell therapy in multiple myeloma.

Haematologica·2026

Same journal

Incidence and predictors of recurrent venous thromboembolism after isolated distal deep vein thrombosis: a <i>post-hoc</i> analysis of the RIDTS trial.

Haematologica·2026

Same journal

Philadelphia positive T-acute lymphoblastic leukemia: a Mayo Clinic series.

Haematologica·2026

Same journal

Long-term follow-up of oral decitabine/cedazuridine plus venetoclax for older or unfit patients with newly diagnosed acute myeloid leukemia.

Haematologica·2026

Same journal

Reframing leukemia-niche interactions: the emerging role of the marrow adipocyte lineage.

Haematologica·2026

Same journal

A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphoma.

Haematologica·2026

Related Experiment Videos

Nail changes after chemotherapy

Related Concept Videos

[Beta-thalassemia, 1998].

[Randomized multi-center trial of the administration of erythropoietin in anemia of prematurity].

[Serum ferritin for screening in fertile-age women].

[Organizational models for the hematology areas of the district hospitals of Catalonia].

[Intense neutropenia of 14 years duration as the only manifestation of a myelodysplastic syndrome].

[Primary extralymphatic non-Hodgkin's lymphomas: the response to treatment and prognostic factors in 73 patients].

Emapalumab and eltrombopag rescue for prolonged immune effector cell-associated hemophagocytic syndrome after CAR T-cell therapy in multiple myeloma.

Incidence and predictors of recurrent venous thromboembolism after isolated distal deep vein thrombosis: a <i>post-hoc</i> analysis of the RIDTS trial.

Philadelphia positive T-acute lymphoblastic leukemia: a Mayo Clinic series.

Long-term follow-up of oral decitabine/cedazuridine plus venetoclax for older or unfit patients with newly diagnosed acute myeloid leukemia.

Reframing leukemia-niche interactions: the emerging role of the marrow adipocyte lineage.

A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphoma.

Related Experiment Videos

Nail changes after chemotherapy

Related Concept Videos

Related Articles

[Beta-thalassemia, 1998].

[Randomized multi-center trial of the administration of erythropoietin in anemia of prematurity].

[Serum ferritin for screening in fertile-age women].

[Organizational models for the hematology areas of the district hospitals of Catalonia].

[Intense neutropenia of 14 years duration as the only manifestation of a myelodysplastic syndrome].

[Primary extralymphatic non-Hodgkin's lymphomas: the response to treatment and prognostic factors in 73 patients].

Emapalumab and eltrombopag rescue for prolonged immune effector cell-associated hemophagocytic syndrome after CAR T-cell therapy in multiple myeloma.

Incidence and predictors of recurrent venous thromboembolism after isolated distal deep vein thrombosis: a <i>post-hoc</i> analysis of the RIDTS trial.

Philadelphia positive T-acute lymphoblastic leukemia: a Mayo Clinic series.

Long-term follow-up of oral decitabine/cedazuridine plus venetoclax for older or unfit patients with newly diagnosed acute myeloid leukemia.

Reframing leukemia-niche interactions: the emerging role of the marrow adipocyte lineage.

A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphoma.